Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $145.6100 (-0.34%) ($143.7400 - $146.1200) on Wed. Sep. 6, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.14% (three month average) | RSI | 24 | Latest Price | $145.6100(-0.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.3% a day on average for past five trading days. | Weekly Trend | ABBV declines -1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(60%) DIA(53%) SPLV(53%) VYM(49%) IBB(48%) | Factors Impacting ABBV price | ABBV will decline at least -0.57% in a week (0% probabilities). VXX(-34%) VIXM(-31%) USO(-20%) TBT(-17%) EDOC(-11%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.57% (StdDev 1.14%) | Hourly BBV | -0.7 () | Intraday Trend | -0.3% | | | |
|
Resistance Level | $148.85 | 5 Day Moving Average | $147.04(-0.97%) | 10 Day Moving Average | $147.05(-0.98%) | 20 Day Moving Average | $148.85(-2.18%) | To recent high | -4.4% | To recent low | 9.9% | Market Cap | $256.897b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |